Featured post

Diphtheria Scare in Edo State: Calls for School Closure Amid Rising Cases

Image
  Edo State is currently battling a public health scare as diphtheria cases emerge, raising concern among residents, health professionals, and civil society. With six confirmed cases and three reported fatalities, the outbreak has prompted urgent calls for preventive measures to contain further spread. Diphtheria is a highly contagious bacterial infection affecting the nose and throat, often fatal if left untreated. The Edo State Ministry of Health has confirmed the detection of both diphtheria and dengue fever, adding complexity to the state’s health response. So far, over 15 suspected diphtheria cases have been identified, with health officials moving swiftly to activate surveillance teams and conduct community sensitization. In a proactive appeal, the Concerned Edo Citizens Forum submitted an open letter to Governor Godwin Obaseki, urging the temporary closure of schools to protect children, who are among the most vulnerable to the disease. The group also recommended limitin...

Nigerian Company To Produce HiV And Malaria Test Kits After US Funding Cuts

In a major step toward health independence, a Nigerian company, Codix Bio Limited, is set to begin the local production of HIV and malaria test kits. This initiative follows significant funding cuts from the United States government, which had previously provided substantial financial support for Nigeria’s health programs through USAID and other agencies.


In 2024 alone, the U.S. contributed over $740 million to Nigeria’s health sector, supporting critical programmes for HIV treatment, malaria prevention, and immunization. However, a recent shift in U.S. foreign aid policy has led to a suspension of new funding, raising serious concerns about the sustainability of these essential services.


To bridge the gap, Codix Bio has partnered with South Korean medical diagnostics firm SD Biosensor, with technical support from the World Health Organization (WHO). The new facility, located near Lagos, is expected to produce up to 147 million test kits annually, a capacity large enough to meet Nigeria’s domestic demand and extend supply to neighbouring African countries.


Nigeria accounts for a significant portion of global malaria cases and ranks fourth globally in terms of HIV burden. The U.S. aid cut could have crippled diagnostic and treatment services, but Codix Bio’s move offers a local solution that may prevent a healthcare crisis.


In response to the funding cuts, the Nigerian government has also approved over ₦200 billion for HIV, tuberculosis, malaria, and immunization programs, showing a renewed commitment to self-reliance in healthcare.


This initiative not only ensures continuity in testing and treatment but also boosts local manufacturing, creates jobs, and strengthens the country’s health infrastructure. Codix Bio’s effort marks a shift from foreign dependency to national self-sufficiency—a necessary evolution for Nigeria’s long-term public health security.


Comments

Popular posts from this blog

Anambra Boutique Owner Sues NAFDAC Over Claimed Theft of Merchandise During Onitsha Drug Market Operation

"Kano girls, having been married off from an orphanage, face abandonment by their husbands and endure abuse, as they are now forced to seek assistance to survive."

Benin Republic, Niger enjoy smuggled fuel as Nigerians keep vigil at petrol stations